What is MNOV's dilution risk score?

MNOV has a latest available DilutionScore record of 26/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for MNOV, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for MNOV?

DilutionWatch tracks 25 SEC filing types for MNOV including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect MNOV shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For MNOV, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for MNOV tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for MNOV. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

MNOV Dilution Risk Score: 26/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

40

💰 Cash Runway

0

📊 Float Risk

7

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 15%

🔄 Reverse Split model est. 30%

• 50-day avg $1.41 approaching $1 threshold

🔔 Track MNOV — Get forecast alerts →

Market Data

Market Cap$66.94M

Shares Outstanding49.22M

Float42.26M

Cash$65.40M

Debt$165.2K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 32.4% shares (2026Q1 vs prior)

30 institutional holders · 7.23M shares

#1 BARCLAYS PLC 1.35M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 1.22M shares

#3 Essex Woodlands Management, Inc. 1.11M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest346.4K

Days to Cover8.8

% of Float0.8%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2012-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual MNOV Dilution Snapshot

MediciNova, Inc. (MNOV) has a DilutionScore of 26/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for MNOV: xbrl on 2012-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

More Research for MNOV

MNOV FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

MNOV — MediciNova, Inc. Dilution Risk Tracker